Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.

Therapies that Ag-specifically target pathologic T lymphocytes responsible for multiple sclerosis (MS) and other autoimmune diseases would be expected to have improved therapeutic indices compared with Ag-nonspecific therapies. We have developed a cellular immunotherapy that uses chimeric receptors...

詳細記述

書誌詳細
主要な著者: Moisini, I, Nguyen, P, Fugger, L, Geiger, T
フォーマット: Journal article
言語:English
出版事項: 2008

類似資料